Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1178 of 5804
-
New targeted drug may improve lymphoma treatment
Disease control Recruiting nowThis study aims to explore a new treatment approach for patients with treatment-naive Marginal Zone Lymphoma (MZL). MZL is a type of slow-growing lymphoma that often affects older adults. The current standard treatment involves chemotherapy, but it can have significant side effec…
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowQLC5508 is a fully humanized IgG1 antibody-drug conjugate (ADC) which specifically binds to B7-H3, a target wildly expressed on solid tumor cells. The objectives of this study are to investigate the safety, tolerability, pharmacokinetics and anti-tumor activity of QLC5508 in comb…
Phase: PHASE1, PHASE2 • Sponsor: Qilu Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Shockwave therapy may crack tough heart artery plaque
Disease control OngoingThe goal of this clinical trial is to investigate whether the clinical outcomes of combined application of intravascular lithotripsy (IVL) following routine preconditioning are superior to those of routine preconditioning alone in patients with moderate-to-severe coronary artery …
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Amniotic grafts show promise for chronic wounds in large Real-World study
Disease control OngoingThis retrospective multi-site observational cohort study uses electronic health records (EHR) from U.S. wound care centers to evaluate the effectiveness of four amniotic membrane allografts (Acesso DL, Acesso TL, Neostim DL, Neostim TL) when added to standard wound care for diabe…
Sponsor: Dynamic Medical Services dba Acesso Biologics • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
AI spots hidden brain aneurysms in routine scans
Diagnosis OngoingThe goal of this clinical trial is to verify the opportunistic screening potential of the AI software for detection of brain unruptured intracranial aneurysms (UIA) on routinely performed brain NECT scans in a prospective setting in the Belgian population. The main question the …
Phase: NA • Sponsor: Ziekenhuis Oost-Limburg • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
Brain pacemaker aims to curb opioid cravings
Disease control Recruiting nowThe purpose of this study is to determine if personalized (adaptive) Deep Brain Stimulation (DBS) based upon invasive brain mapping is safe and can lead to better outcomes like reductions in craving and opioid use.
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Heart failure in women: could a social worker be the missing prescription?
Disease control Recruiting nowBackground: Heart Failure (HF) is the second most common cause of hospitalizations for women in North America. Non-adherence to guideline-directed medical therapy (GDMT) is associated with 50% of all treatment failures and high rates of hospitalizations and death. A recent Canadi…
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Could a daily pill replace needles for hemophilia a?
Disease control Recruiting nowThis study will test how different doses of study medicine (Inno8) work in the bodies of people with haemophilia A. The purpose of the study is to see if Inno8 is safe to use for people with haemophilia A. The study medicine is a new medicine that cannot yet be prescribed by doct…
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can magnetic waves tame autoimmune disease? new trial begins
Disease control ENROLLING_BY_INVITATIONThe ImmuneNet study is a Phase I/II clinical trial sponsored by Truway Health, Inc. It will test whether gentle, low-frequency electromagnetic resonance (LF-EMR) can influence how immune cells communicate and synchronize with each other. The goal is to see if this "quantum-synapt…
Phase: PHASE1, PHASE2 • Sponsor: Truway Health, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Smart scale for swelling: could a Foot-Volume monitor keep heart patients out of hospital?
Disease control Recruiting nowThis pragmatic randomized crossover trial looks at the effect(s) of using a remote patient monitoring device (Heartfelt device) with health alerts to monitor the development of peripheral edema in patients with heart failure (HF). The hypothesis is that this passive measurement m…
Phase: NA • Sponsor: Heartfelt Technologies • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can a smartphone app curb teen suicide risk?
Symptom relief ENROLLING_BY_INVITATIONThe primary objective of this study is to assess the efficacy of a digital intervention in reducing suicidal ideation in adolescents.
Phase: NA • Sponsor: Oui Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
New heart device aims to clear toughest blockages
Disease control Recruiting nowClinical research with medical devices indicated in accordance with the CE marking, led by researchers, multicenter, open, prospective, randomized and controlled. Patients are randomized to treatment with a conventional balloon and then a coronary stent or to initial plaque modif…
Phase: NA • Sponsor: Fundación EPIC • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Dissolvable heart scaffolds take on drug balloons in major artery showdown
Disease control Not yet recruitingThis study plans to enroll 150 patients who are candidates for "intervention without implantation" therapy and they will be randomly assigned in a 1:1 ratio to either the new-generation Firesorb scaffold group (BRS group, N=75) or the drug-coated balloon group (DCB group, N=75). …
Phase: NA • Sponsor: Xuzhou Third People's Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:45 UTC
-
New pill aims to tame chaotic heartbeats in atrial fibrillation
Disease control Recruiting nowA clinical Randomized Phase 2 Trial of AP31969 versus Placebo for Rhythm Control of Atrial Fibrillation.
Phase: PHASE2 • Sponsor: Acesion Pharma • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New combo therapy hopes to slow sarcoma growth
Disease control Recruiting nowThe investigators hypothesize that the combination of eribulin and zanzalintinib will be tolerable and lead to improved progression-free survival (PFS) as compared to eribulin alone based on historical data.
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
At-Home HPV test could boost screening in underserved women
Diagnosis Recruiting nowPhase I: Validating self-collection kit by comparing their results with clinical Pap smear results in a cohort of 20 patients. Phase II: Evaluate the feasibility and acceptability of the CHW4CervicalHealth: Use of a self-collection kit to improve cervical health screening interv…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
New hope for kids with AML: gentler chemo combos under trial
Disease control Recruiting nowThis research study investigates the tolerability of substituting two cycles of chemotherapy into the standard pediatric acute myeloid leukemia (AML) chemotherapy treatment regimen for patients with newly diagnosed AML at intermediate-risk (IR) and high-risk (HR) of relapse. The …
Phase: EARLY_PHASE1 • Sponsor: Joanna Yi • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
AI eye test could catch glaucoma early in underserved communities
Diagnosis Recruiting nowThe goal of this clinical trial is to learn if implementation of an eye screening program at Federally Qualified Health Center (FQHC) clinics provides results that participants may have glaucoma, and/or other eye conditions (diabetic retinopathy, cataract, visual acuity impairmen…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
AI coach aims to cut hospital stays for millions with chronic disease
Disease control Recruiting nowThe primary objective of CHAPERONE solution is to evaluate the efficacy of engaging, assessing, and enabling long term treatment strategy with Health Artificial Intelligence (AI) Chatbot, Copilot, Large Language Model (LLM) and vital sign monitoring device in reducing CKM disease…
Phase: NA • Sponsor: Aventyn, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Could a common probiotic soothe IBS? new trial seeks answers
Symptom relief Recruiting nowThis is a double-blind, randomized (group assignment by chance), placebo-controlled, multicenter trial which will be conducted over a 13.5-months period The main objective of the research is to demonstrate the efficacy of Saccharomyces boulardii CNCM I-745 on global IBS symptoms,…
Phase: PHASE3 • Sponsor: Biocodex • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC